Drug Profile
AGS 16M18
Alternative Names: AGS-16M18Latest Information Update: 04 Jun 2010
Price :
$50
*
At a glance
- Originator Agensys
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Surface antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Cancer
Most Recent Events
- 02 Feb 2010 Phase-I development is ongoing in USA and Canada